The effect of denosmab on osteoporosis related to Parkinson's disease and glucocorticoid-induced osteoporosis
Not Applicable
- Conditions
- osteoporosis, Parkinson's disease neuroimmunological disease
- Registration Number
- JPRN-UMIN000025056
- Lead Sponsor
- The Jikei University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Current or previous use of denosumab (2)Patients with renal insufficiency (CCr <30ml/min) (3)Patients with hypocalcemia(serum calcium<8.4mg/dl) (4)Female patients who are pregnant, trying to become pregnant or nursing (lactating) an infant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method